PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $27,000 | -40.0% | 450 | -43.4% | 0.00% | -50.0% |
Q3 2021 | $45,000 | -6.2% | 795 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $48,000 | -14.3% | 795 | 0.0% | 0.00% | -20.0% |
Q1 2021 | $56,000 | -35.6% | 795 | -45.2% | 0.01% | -37.5% |
Q4 2020 | $87,000 | 0.0% | 1,450 | 0.0% | 0.01% | -11.1% |
Q3 2020 | $87,000 | – | 1,450 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 2,799,916 | $121,768,000 | 8.62% |
Tamarack Advisers, LP | 625,000 | $27,044,000 | 8.22% |
NEXTHERA CAPITAL LP | 149,086 | $6,484,000 | 5.40% |
Spyglass Capital Management LLC | 379,609 | $16,509,000 | 5.22% |
Gagnon Advisors, LLC | 107,412 | $4,671,000 | 2.67% |
GAGNON SECURITIES LLC | 278,613 | $12,117,000 | 2.61% |
Asymmetry Capital Management, L.P. | 84,735 | $3,685,000 | 2.00% |
Rock Springs Capital Management LP | 1,250,000 | $54,363,000 | 1.97% |
Lisanti Capital Growth, LLC | 118,620 | $5,159,000 | 1.68% |
Elk Creek Partners, LLC | 500,069 | $21,748,000 | 1.62% |